Piramal Pharma Limited

Form 483 issued February 17, 2025 · Navi Mumbai, India

Inspection
Feb 17, 2025
Investigator
Guerlain Ulysse
Observations
5
Pages
10
FEI number
3008763768

In short: On February 17, 2025, FDA issued a Form 483 with 5 observations to Piramal Pharma Limited in Navi Mumbai, Maharashtra (FEI 3008763768) after an inspection that ran Feb 17, 2025. The investigator was Guerlain Ulysse. Most observations concern quality system and facilities & equipment.

At a glance

3 of 5 observations on this 483 concern quality system.

Quality system3
Facilities & equipment1
Production1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The responsibilities and procedures applicable to the quality control unit are not in…

  2. 02

    Written records of investigation of an active pharmaceutical ingredient (API)…

  3. 03

    Written records of investigation of an API complaint do…

  4. 04

    The cleaning of equipment…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Piramal Pharma Limited?

FDA listed 5 observations on this Form 483, mostly about quality system, facilities & equipment and production. The opening words of each observation are shown on this page.

Who inspected Piramal Pharma Limited?

Guerlain Ulysse is named on this Form 483, for the inspection of Feb 17, 2025. Each investigator has a profile showing what they cite most.

When was Piramal Pharma Limited inspected by FDA?

The inspection ran Feb 17, 2025, and the Form 483 is dated February 17, 2025.

How do I get the full Form 483 for Piramal Pharma Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free